SmithKline Beecham's chief scientific officer, George Poste, speaks of pharmacogenomics as the savior of the industry.

FORBES: Tailor-made drugs

Among the first to recognize this potential was George Poste, former chief scientist for SmithKline Beecham.

FORBES: Divining Disease

Allison and George Poste, NATO ASI Series, Series A: Life Sciences Vol. 179, (ISBN 0-306-43386-9), 1989, Plenum Press, New York.

FORBES: Extradite Andrew Wakefield To Face Fraud Charges In The UK